A short fitness clip pushing back on stigma around GLP-1 drugs. Light on detail beyond the message itself.
Recap by typeshit. Video by Ryan Lill-Washington on TikTok.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
In data shown at the EADV Congress in Vienna, 39% of GLP-1 users reported nails lifting versus 9% of non-users. Researchers say the findings are self-reported and show association, not cause.
A short reply clip on vision concerns tied to GLP-1 medications, a question that has followed reports of NAION eye stroke risk.
Loading…